Fish Testing News Today

The role of HER2 status and targeted therapy with trastuzumab in advanced endometrial cancer, emphasizing the need for effective management of cardiac toxicities and comorbidities.

Key opinion leaders review the evolution of Ph+ ALL treatment, from Hyper-CVAD to novel TKIs, blinatumomab, and deintensification, improving remission rates and survival.

An expert on colorectal cancer discusses the relationship between HER2 status and treatment selection and response.

Shared perspective on the armamentarium of molecular testing assays in non–small cell lung cancer and how results can be best interpreted when selecting treatment.

Broadening their conversation, expert oncologists define the treatment algorithm for patients diagnosed with colorectal cancer.

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process.

TSCA/FIFRA/TRI - PODCAST - Trends In Product Sustainability And Circularity — A Conversation With Kate Sellers: In this episode Lynn L. Bergeson sits down with Kate Seller...

In this Episode Lynn L. Bergeson sits down with Kate Sellers, Technical Fellow at ERM, to discuss the business value of product stewardship, including…

The U.S. Environmental Protection Agency (EPA) announced on April 18, 2022, that it will hold a webinar on May 11, 2022, entitled “Data-Driven Solutions to Reducing Animal Use in...

Carlie LaLone, Ph.D., EPA Office of Research and Development ORD, on The Sequence Alignment to Predict Across Species Susceptibility SeqAPASS Tool: Extrapolating Knowledge Computationally. EPA states that regulatory decision-making for chemical safety relies upon toxicity data.